{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:28:34Z","timestamp":1793219314863,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T00:00:00Z","timestamp":1706227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T00:00:00Z","timestamp":1706227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mild behavioral impairment (MBI) has been commonly reported in early Alzheimer\u2019s disease (AD) but rarely using biomarker-defined samples. It is also unclear whether genetic polymorphisms influence MBI in such individuals. We thus aimed to examine the association between the cognitive status of participants (amnestic mild cognitive impairment (aMCI-AD) vs cognitively normal (CN) older adults) and MBI severity. Within aMCI-AD, we further examined the association between APOE and BDNF risk genetic polymorphisms and MBI severity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We included 62 aMCI-AD participants and 50 CN older adults from the Czech Brain Aging Study. The participants underwent neurological, comprehensive neuropsychological examination, APOE and BDNF genotyping, and magnetic resonance imaging. MBI was diagnosed with the Mild Behavioral Impairment Checklist (MBI-C), and the diagnosis was based on the MBI-C total score\u2009\u2265\u20097. Additionally, self-report instruments for anxiety (the Beck Anxiety Inventory) and depressive symptoms (the Geriatric Depression Scale-15) were administered. The participants were stratified based on the presence of at least one risk allele in genes for APOE (i.e., e4 carriers and non-carriers) and BDNF (i.e., Met carriers and non-carriers). We used linear regressions to examine the associations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>MBI was present in 48.4% of the aMCI-AD individuals. Compared to the CN, aMCI-AD was associated with more affective, apathy, and impulse dyscontrol but not social inappropriateness or psychotic symptoms. Furthermore, aMCI-AD was related to more depressive but not anxiety symptoms on self-report measures. Within the aMCI-AD, there were no associations between <jats:italic>APOE<\/jats:italic> e4 and <jats:italic>BDNF<\/jats:italic> Met and MBI-C severity. However, a positive association between Met carriership and self-reported anxiety appeared.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>MBI is frequent in aMCI-AD and related to more severe affective, apathy, and impulse dyscontrol symptoms. <jats:italic>APOE<\/jats:italic> and <jats:italic>BDNF<\/jats:italic> polymorphisms were not associated with MBI severity separately; however, their combined effect warrants further investigation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-024-01386-y","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T05:02:02Z","timestamp":1706245322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Mild behavioral impairment in early Alzheimer\u2019s disease and its association with APOE and BDNF risk genetic polymorphisms"],"prefix":"10.1186","volume":"16","author":[{"given":"Veronika","family":"Matuskova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Veverova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan J.","family":"Jester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaclav","family":"Matoska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahinoor","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Sheardova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Horakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Cerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Lacz\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Andel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Hort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Vyhnalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,26]]},"reference":[{"issue":"3","key":"1386_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1386_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):270\u20139.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1386_CR3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"11","key":"1386_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.dadm.2019.02.006","volume":"18","author":"EA Wise","year":"2019","unstructured":"Wise EA, Rosenberg PB, Lyketsos CG, Leoutsakos JM. Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer\u2019s Coordinating Centers volunteers. Alzheimers Dement (Amst). 2019;18(11):333\u20139.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"1386_CR5","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1038\/s41598-021-83126-y","volume":"11","author":"N Roberto","year":"2021","unstructured":"Roberto N, Portella MJ, Marqui\u00e9 M, Alegret M, Hern\u00e1ndez I, Maule\u00f3n A, et al. Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis. Sci Rep. 2021;11(1):6448.","journal-title":"Sci Rep"},{"issue":"1","key":"1386_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/13607863.2014.915922","volume":"19","author":"M Paradise","year":"2015","unstructured":"Paradise M, McCade D, Hickie IB, Diamond K, Lewis SJG, Naismith SL. Caregiver burden in mild cognitive impairment. Aging Ment Health. 2015;19(1):72\u20138.","journal-title":"Aging Ment Health"},{"issue":"2","key":"1386_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jalz.2015.05.017","volume":"12","author":"Z Ismail","year":"2016","unstructured":"Ismail Z, Smith EE, Geda Y, Sultzer D, Brodaty H, Smith G, et al. Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement. 2016;12(2):195\u2013202.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1386_CR8","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3233\/JAD-160979","volume":"56","author":"Z Ismail","year":"2017","unstructured":"Ismail Z, Ag\u00fcera-Ortiz L, Brodaty H, Cieslak A, Cummings J, Fischer CE, et al. The Mild Behavioral Impairment Checklist (MBI-C): a rating scale for neuropsychiatric symptoms in pre-dementia populations. J Alzheimers Dis. 2017;56(3):929\u201338.","journal-title":"J Alzheimers Dis"},{"key":"1386_CR9","first-page":"089198872210933","volume":"17","author":"S Hu","year":"2022","unstructured":"Hu S, Patten S, Charlton A, Fischer K, Fick G, Smith EE, et al. Validating the mild behavioral impairment checklist in a cognitive clinic: comparisons with the Neuropsychiatric Inventory Questionnaire. J Geriatr Psychiatry Neurol. 2022;17:08919887221093353.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"1","key":"1386_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3233\/JAD-180131","volume":"66","author":"SC Mallo","year":"2018","unstructured":"Mallo SC, Ismail Z, Pereiro AX, Facal D, Lojo-Seoane C, Campos-Magdaleno M, et al. Assessing mild behavioral impairment with the Mild Behavioral Impairment-Checklist in people with mild cognitive impairment. J Alzheimers Dis. 2018;66(1):83\u201395.","journal-title":"J Alzheimers Dis"},{"key":"1386_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/psyg.12295","volume":"18","author":"SC Mallo","year":"2018","unstructured":"Mallo SC, Ismail Z, Pereiro AX, Facal D, Lojo-Seoane C, Campos-Magdaleno M, et al. Assessing mild behavioral impairment with the mild behavioral impairment checklist in people with subjective cognitive decline. Int Psychogeriatr. 2018;18:1\u20139.","journal-title":"Int Psychogeriatr"},{"issue":"13","key":"1386_CR12","doi-asserted-by":"publisher","first-page":"e1276","DOI":"10.1212\/WNL.0000000000012598","volume":"97","author":"WS Eikelboom","year":"2021","unstructured":"Eikelboom WS, van den Berg E, Singleton EH, Baart SJ, Coesmans M, Leeuwis AE, et al. Neuropsychiatric and cognitive symptoms across the Alzheimer disease clinical spectrum: cross-sectional and longitudinal associations. Neurology. 2021;97(13):e1276\u201387.","journal-title":"Neurology"},{"issue":"6","key":"1386_CR13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2174\/1567205018666211001113349","volume":"18","author":"Y Wang","year":"2021","unstructured":"Wang Y, Lou F, Li Y, Liu F, Wang Y, Cai L, et al. Clinical, neuropsychological, and neuroimaging characteristics of amyloid-positive vs. amyloid-negative patients with clinically diagnosed Alzheimer\u2019s disease and amnestic mild cognitive impairment. Curr Alzheimer Res. 2021;18(6):523\u201332.","journal-title":"Curr Alzheimer Res"},{"issue":"5 Suppl 6","key":"1386_CR14","first-page":"S10","volume":"48","author":"JL Cummings","year":"1997","unstructured":"Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology. 1997;48(5 Suppl 6):S10-16.","journal-title":"Neurology"},{"issue":"1\u20132","key":"1386_CR15","first-page":"165","volume":"5","author":"JI Sheikh","year":"1986","unstructured":"Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986;5(1\u20132):165\u201373.","journal-title":"Clin Gerontol"},{"issue":"6","key":"1386_CR16","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","volume":"56","author":"AT Beck","year":"1988","unstructured":"Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893\u20137.","journal-title":"J Consult Clin Psychol"},{"issue":"107","key":"1386_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.neubiorev.2019.09.014","volume":"1","author":"LCP Banning","year":"2019","unstructured":"Banning LCP, Ramakers IHGB, Deckers K, Verhey FRJ, Aalten P. Affective symptoms and AT(N) biomarkers in mild cognitive impairment and Alzheimer\u2019s disease: a systematic literature review. Neurosci Biobehav Rev. 2019;1(107):346\u201359.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"1386_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40035-021-00236-3","volume":"10","author":"KP Ng","year":"2021","unstructured":"Ng KP, Chiew H, Rosa-Neto P, Kandiah N, Ismail Z, Gauthier S. Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer\u2019s disease and cognitively unimpaired individuals. Transl Neurodegener. 2021;10(1):11.","journal-title":"Transl Neurodegener"},{"issue":"2","key":"1386_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1017\/S1041610217001909","volume":"30","author":"ME Mortby","year":"2018","unstructured":"Mortby ME, Ismail Z, Anstey KJ. Prevalence estimates of mild behavioral impairment in a population-based sample of pre-dementia states and cognitively healthy older adults. Int Psychogeriatr. 2018;30(2):221\u201332.","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"1386_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1017\/S104161021700151X","volume":"30","author":"F Sheikh","year":"2018","unstructured":"Sheikh F, Ismail Z, Mortby ME, Barber P, Cieslak A, Fischer K, et al. Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden. Int Psychogeriatr. 2018;30(2):233\u201344.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"1386_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13195-021-00949-7","volume":"14","author":"B Creese","year":"2022","unstructured":"Creese B, Ismail Z. Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer\u2019s disease. Alzheimers Res Ther. 2022;14(1):2.","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"1386_CR22","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jalz.2012.12.001","volume":"9","author":"YE Geda","year":"2013","unstructured":"Geda YE, Schneider LS, Gitlin LN, Miller DS, Smith GS, Bell J, et al. Neuropsychiatric symptoms in Alzheimer\u2019s disease: past progress and anticipation of the future. Alzheimers Dement. 2013;9(5):602\u20138.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"1386_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9(2):106\u201318.","journal-title":"Nat Rev Neurol"},{"key":"1386_CR24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev.med.47.1.387","volume":"47","author":"AD Roses","year":"1996","unstructured":"Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer\u2019s disease. Annu Rev Med. 1996;47:387\u2013400.","journal-title":"Annu Rev Med"},{"issue":"5","key":"1386_CR25","first-page":"e650","volume":"96","author":"RL Joie","year":"2021","unstructured":"Joie RL, Visani AV, Lesman-Segev OH, Baker SL, Edwards L, Iaccarino L, et al. Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau- and amyloid-PET. Neurology. 2021;96(5):e650\u201361.","journal-title":"Neurology"},{"issue":"11","key":"1386_CR26","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.jalz.2017.03.002","volume":"13","author":"NME Scheltens","year":"2017","unstructured":"Scheltens NME, Tijms BM, Koene T, Barkhof F, Teunissen CE, Wolfsgruber S, et al. Cognitive subtypes of probable Alzheimer\u2019s disease robustly identified in four cohorts. Alzheimers Dement. 2017;13(11):1226\u201336.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"1386_CR27","doi-asserted-by":"publisher","first-page":"e607","DOI":"10.1212\/WNL.0000000000008666","volume":"94","author":"S Weintraub","year":"2020","unstructured":"Weintraub S, Teylan M, Rader B, Chan KCG, Bollenbeck M, Kukull WA, et al. APOE is a correlate of phenotypic heterogeneity in Alzheimer disease in a national cohort. Neurology. 2020;94(6):e607\u201312.","journal-title":"Neurology"},{"issue":"2","key":"1386_CR28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/156720510790691173","volume":"7","author":"B Borroni","year":"2010","unstructured":"Borroni B, Costanzi C, Padovani A. Genetic susceptibility to behavioural and psychological symptoms in Alzheimer disease. Curr Alzheimer Res. 2010;7(2):158\u201364.","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"1386_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.arr.2011.06.005","volume":"11","author":"F Panza","year":"2012","unstructured":"Panza F, Frisardi V, Seripa D, D\u2019Onofrio G, Santamato A, Masullo C, et al. Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer\u2019s disease. Ageing Res Rev. 2012;11(1):87\u2013103.","journal-title":"Ageing Res Rev"},{"key":"1386_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neubiorev.2017.01.028","volume":"75","author":"RSM Tsang","year":"2017","unstructured":"Tsang RSM, Mather KA, Sachdev PS, Reppermund S. Systematic review and meta-analysis of genetic studies of late-life depression. Neurosci Biobehav Rev. 2017;75:129\u201339.","journal-title":"Neurosci Biobehav Rev"},{"issue":"96","key":"1386_CR31","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.neubiorev.2018.11.020","volume":"1","author":"LCP Banning","year":"2019","unstructured":"Banning LCP, Ramakers IHGB, Deckers K, Verhey FRJ, Aalten P. Apolipoprotein E and affective symptoms in mild cognitive impairment and Alzheimer\u2019s disease dementia: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2019;1(96):302\u201315.","journal-title":"Neurosci Biobehav Rev"},{"issue":"12","key":"1386_CR32","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.jagp.2016.08.007","volume":"24","author":"SE Holmes","year":"2016","unstructured":"Holmes SE, Esterlis I, Mazure CM, Lim YY, Ames D, Rainey-Smith S, et al. \u03b2-Amyloid, APOE and BDNF genotype, and depressive and anxiety symptoms in cognitively normal older women and men. Am J Geriatr Psychiatry. 2016;24(12):1191\u20135.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"8","key":"1386_CR33","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/ajmg.b.32684","volume":"177","author":"SJ Andrews","year":"2018","unstructured":"Andrews SJ, Ismail Z, Anstey KJ, Mortby M. Association of Alzheimer\u2019s genetic loci with mild behavioral impairment. Am J Med Genet B Neuropsychiatr Genet. 2018;177(8):727\u201335.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"1386_CR34","doi-asserted-by":"publisher","first-page":"e12370","DOI":"10.1002\/trc2.12370","volume":"8","author":"D Vellone","year":"2022","unstructured":"Vellone D, Ghahremani M, Goodarzi Z, Forkert ND, Smith EE, Ismail Z. Apathy and APOE in mild behavioral impairment, and risk for incident dementia. Alzheimers Dement (N Y). 2022;8(1):e12370.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"4","key":"1386_CR35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/brainsci10040195","volume":"10","author":"DT Brown","year":"2020","unstructured":"Brown DT, Vickers JC, Stuart KE, Cechova K, Ward DD. The BDNF Val66Met polymorphism modulates resilience of neurological functioning to brain ageing and dementia: a narrative review. Brain Sci. 2020;10(4):195.","journal-title":"Brain Sci"},{"issue":"5","key":"1386_CR36","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/ajmg.b.32062","volume":"159B","author":"Y Pei","year":"2012","unstructured":"Pei Y, Smith AK, Wang Y, Pan Y, Yang J, Chen Q, et al. The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis. Am J Med Genet B Neuropsychiatr Genet. 2012;159B(5):560\u20136.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"7","key":"1386_CR37","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1001\/jamapsychiatry.2017.0660","volume":"74","author":"A Singh-Manoux","year":"2017","unstructured":"Singh-Manoux A, Dugravot A, Fournier A, Abell J, Ebmeier K, Kivim\u00e4ki M, et al. Trajectories of depressive symptoms before diagnosis of dementia. JAMA Psychiat. 2017;74(7):712\u20138.","journal-title":"JAMA Psychiat"},{"issue":"2","key":"1386_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3233\/JAD-2012-111922","volume":"31","author":"K Steenland","year":"2012","unstructured":"Steenland K, Karnes C, Seals R, Carnevale C, Hermida A, Levey A. Late-life depression as a risk factor for mild cognitive impairment or Alzheimer\u2019s disease in 30 US Alzheimer\u2019s disease centers. J Alzheimers Dis. 2012;31(2):265\u201375.","journal-title":"J Alzheimers Dis"},{"key":"1386_CR39","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.eurpsy.2017.02.486","volume":"43","author":"V Tapiainen","year":"2017","unstructured":"Tapiainen V, Hartikainen S, Taipale H, Tiihonen J, Tolppanen AM. Hospital-treated mental and behavioral disorders and risk of Alzheimer\u2019s disease: a nationwide nested case-control study. Eur Psychiatry. 2017;43:92\u20138.","journal-title":"Eur Psychiatry"},{"issue":"9","key":"1386_CR40","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.neurobiolaging.2007.11.023","volume":"30","author":"B Borroni","year":"2009","unstructured":"Borroni B, Archetti S, Costanzi C, Grassi M, Ferrari M, Radeghieri A, et al. Role of BDNF Val66Met functional polymorphism in Alzheimer\u2019s disease-related depression. Neurobiol Aging. 2009;30(9):1406\u201312.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1386_CR41","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3233\/JAD-2011-110113","volume":"26","author":"L Zhang","year":"2011","unstructured":"Zhang L, Fang Y, Zeng Z, Lian Y, Wei J, Zhu H, et al. BDNF gene polymorphisms are associated with Alzheimer\u2019s disease-related depression and antidepressant response. J Alzheimers Dis. 2011;26(3):523\u201330.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1386_CR42","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/gps.4761","volume":"33","author":"SE Holmes","year":"2018","unstructured":"Holmes SE, Esterlis I, Mazure CM, Lim YY, Ames D, Rainey-Smith S, et al. Trajectories of depressive and anxiety symptoms in older adults: a 6-year prospective cohort study. Int J Geriatr Psychiatry. 2018;33(2):405\u201313.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"4","key":"1386_CR43","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00702-013-1121-y","volume":"121","author":"T Nagata","year":"2014","unstructured":"Nagata T, Kobayashi N, Shinagawa S, Yamada H, Kondo K, Nakayama K. Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease. J Neural Transm. 2014;121(4):433\u201341.","journal-title":"J Neural Transm"},{"issue":"1","key":"1386_CR44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3233\/JAD-190464","volume":"73","author":"K Cechova","year":"2020","unstructured":"Cechova K, Andel R, Angelucci F, Chmatalova Z, Markova H, Lacz\u00f3 J, et al. Impact of APOE and BDNF Val66Met gene polymorphisms on cognitive functions in patients with amnestic mild cognitive impairment. J Alzheimers Dis. 2020;73(1):247\u201357.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"1386_CR45","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3233\/JAD-200615","volume":"78","author":"J Lacz\u00f3","year":"2020","unstructured":"Lacz\u00f3 J, Cechova K, Parizkova M, Lerch O, Andel R, Matoska V, et al. The combined effect of APOE and BDNF Val66Met polymorphisms on spatial navigation in older adults. J Alzheimers Dis. 2020;78(4):1473\u201392.","journal-title":"J Alzheimers Dis"},{"issue":"13","key":"1386_CR46","doi-asserted-by":"publisher","first-page":"643271","DOI":"10.3389\/fnagi.2021.643271","volume":"24","author":"V Matuskova","year":"2021","unstructured":"Matuskova V, Ismail Z, Nikolai T, Markova H, Cechova K, Nedelska Z, et al. Mild behavioral impairment is associated with atrophy of entorhinal cortex and hippocampus in a memory clinic cohort. Front Aging Neurosci. 2021;24(13):643271.","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"1386_CR47","doi-asserted-by":"publisher","first-page":"e030379","DOI":"10.1136\/bmjopen-2019-030379","volume":"9","author":"K Sheardova","year":"2019","unstructured":"Sheardova K, Vyhnalek M, Nedelska Z, Laczo J, Andel R, Marciniak R, et al. Czech Brain Aging Study (CBAS): prospective multicentre cohort study on risk and protective factors for dementia in the Czech Republic. BMJ Open. 2019;9(12):e030379.","journal-title":"BMJ Open"},{"issue":"3","key":"1386_CR48","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3233\/JAD-170595","volume":"61","author":"T Nikolai","year":"2018","unstructured":"Nikolai T, Stepankova H, Kopecek M, Sulc Z, Vyhnalek M, Bezdicek O. The uniform data set, Czech version: normative data in older adults from an international perspective. J Alzheimers Dis. 2018;61(3):1233\u201340.","journal-title":"J Alzheimers Dis"},{"issue":"111","key":"1386_CR49","doi-asserted-by":"publisher","first-page":"292","DOI":"10.14735\/amcsnn2015292","volume":"78","author":"T Nikolai","year":"2015","unstructured":"Nikolai T, \u0160t\u011bp\u00e1nkov\u00e1 H, Michalec J, Bezd\u00ed\u010dek O, Hor\u00e1kov\u00e1 K, Markov\u00e1 H, et al. Verbal Fluency Tests \u2013 Czech normative study for older persons. Cesk Slov Neurol N. 2015;78(111):292\u20139.","journal-title":"Cesk Slov Neurol N"},{"issue":"111","key":"1386_CR50","first-page":"542","volume":"78","author":"K Drozdov\u00e1","year":"2015","unstructured":"Drozdov\u00e1 K, \u0160t\u011bp\u00e1nkov\u00e1 H, Lukavsk\u00fd J, Bezd\u00ed\u010dek O, Kope\u010dek M. Normative data for the Rey- Osterrieth Complex Figure Test in older Czech adults. Cesk Slov Neurol N. 2015;78(111):542\u20139.","journal-title":"Cesk Slov Neurol N"},{"issue":"8","key":"1386_CR51","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1080\/13803395.2015.1057106","volume":"37","author":"O Bezdicek","year":"2015","unstructured":"Bezdicek O, Lukavsky J, Stepankova H, Nikolai T, Axelrod BN, Michalec J, et al. The Prague Stroop Test: normative standards in older Czech adults and discriminative validity for mild cognitive impairment in Parkinson\u2019s disease. J Clin Exp Neuropsychol. 2015;37(8):794\u2013807.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"1","key":"1386_CR52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.14735\/amcsnn202064","volume":"83","author":"V Matuskova","year":"2020","unstructured":"Matuskova V, Nikolai T, Markova H, Cechova K, Laczo J, Hort J, et al. Neuropsychiatrick\u00e9 symptomy jako \u010dasn\u00e1 manifestace Alzheimerovy nemoci. Cesk Slov Neurol N. 2020;83(1):64\u201372.","journal-title":"Cesk Slov Neurol N"},{"key":"1386_CR53","first-page":"1","volume":"8","author":"F Kassam","year":"2022","unstructured":"Kassam F, Chen H, Nosheny RL, McGirr A, Williams T, Ng N, et al. Cognitive profile of people with mild behavioral impairment in Brain Health Registry participants. Int Psychogeriatr. 2022;8:1\u201310.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"1386_CR54","doi-asserted-by":"publisher","first-page":"e12371","DOI":"10.1002\/trc2.12371","volume":"9","author":"M Ghahremani","year":"2023","unstructured":"Ghahremani M, Nathan S, Smith EE, McGirr A, Goodyear B, Ismail Z. Functional connectivity and mild behavioral impairment in dementia-free elderly. Alzheimers Dement. 2023;9(1):e12371.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1386_CR55","first-page":"e12164","volume":"13","author":"B Creese","year":"2021","unstructured":"Creese B, Arathimos R, Brooker H, Aarsland D, Corbett A, Lewis C, et al. Genetic risk for Alzheimer\u2019s disease, cognition, and mild behavioral impairment in healthy older adults. Alzheimers Dement. 2021;13(1):e12164.","journal-title":"Alzheimers Dement"},{"issue":"11","key":"1386_CR56","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1017\/S1041610214001537","volume":"26","author":"LN Gitlin","year":"2014","unstructured":"Gitlin LN, Marx KA, Stanley IH, Hansen BR, Van Haitsma KS. Assessing neuropsychiatric symptoms in people with dementia: a systematic review of measures. Int Psychogeriatr. 2014;26(11):1805\u201348.","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"1386_CR57","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0022-2275(20)43176-1","volume":"31","author":"JE Hixson","year":"1990","unstructured":"Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31(3):545\u20138.","journal-title":"J Lipid Res"},{"issue":"4","key":"1386_CR58","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000321581","volume":"8","author":"J Lacz\u00f3","year":"2011","unstructured":"Lacz\u00f3 J, Andel R, Vl\u010dek K, Maco\u0161ka V, Vyhn\u00e1lek M, Tolar M, et al. Spatial navigation and APOE in amnestic mild cognitive impairment. Neurodegener Dis. 2011;8(4):169\u201377.","journal-title":"Neurodegener Dis"},{"issue":"1","key":"1386_CR59","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jalz.2011.07.004","volume":"8","author":"H Vanderstichele","year":"2012","unstructured":"Vanderstichele H, Bibl M, Engelborghs S, Le Bastard N, Lewczuk P, Molinuevo JL, et al. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer\u2019s disease diagnosis: a consensus paper from the Alzheimer\u2019s Biomarkers Standardization Initiative. Alzheimers Dement. 2012;8(1):65\u201373.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"1386_CR60","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00259-018-4140-y","volume":"46","author":"O Belohlavek","year":"2019","unstructured":"Belohlavek O, Jaruskova M, Skopalova M, Szarazova G, Simonova K. Improved beta-amyloid PET reproducibility using two-phase acquisition and grey matter delineation. Eur J Nucl Med Mol Imaging. 2019;46(2):297\u2013303.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"1386_CR61","doi-asserted-by":"publisher","first-page":"e683","DOI":"10.1212\/WNL.0000000000201517","volume":"100","author":"M Ghahremani","year":"2023","unstructured":"Ghahremani M, Wang M, Chen HY, Zetterberg H, Smith E, Ismail Z, et al. Plasma phosphorylated tau at threonine 181 and neuropsychiatric symptoms in preclinical and prodromal Alzheimer disease. Neurology. 2023;100(7):e683\u201393.","journal-title":"Neurology"},{"issue":"1","key":"1386_CR62","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/alz.12007","volume":"16","author":"FZ Lussier","year":"2020","unstructured":"Lussier FZ, Pascoal TA, Chamoun M, Therriault J, Tissot C, Savard M, et al. Mild behavioral impairment is associated with \u03b2-amyloid but not tau or neurodegeneration in cognitively intact elderly individuals. Alzheimers Dement. 2020;16(1):192\u20139.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1386_CR63","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41398-021-01206-z","volume":"11","author":"M Johansson","year":"2021","unstructured":"Johansson M, Stomrud E, Insel PS, Leuzy A, Johansson PM, Smith R, et al. Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer\u2019s disease. Transl Psychiatry. 2021;11(1):76.","journal-title":"Transl Psychiatry"},{"key":"1386_CR64","doi-asserted-by":"publisher","unstructured":"Kianimehr G, Fatehi F, Noroozian M. Prevalence of mild behavioral impairment in patients with mild cognitive impairment. Acta Neurol Belg. 2022;122:1493\u20137.https:\/\/doi.org\/10.1007\/s13760-021-01724-z.","DOI":"10.1007\/s13760-021-01724-z"},{"issue":"1","key":"1386_CR65","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/psyg.12636","volume":"21","author":"Y Pan","year":"2021","unstructured":"Pan Y, Shea YF, Li S, Chen R, Mak HKF, Chiu PKC, et al. Prevalence of mild behavioural impairment: a systematic review and meta-analysis. Psychogeriatrics. 2021;21(1):100\u201311.","journal-title":"Psychogeriatrics"},{"issue":"10","key":"1386_CR66","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1001\/archpsyc.65.10.1193","volume":"65","author":"YE Geda","year":"2008","unstructured":"Geda YE, Roberts RO, Knopman DS, Petersen RC, Christianson TJH, Pankratz VS, et al. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study. Arch Gen Psychiatry. 2008;65(10):1193\u20138.","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"1386_CR67","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jagp.2013.01.006","volume":"21","author":"PB Rosenberg","year":"2013","unstructured":"Rosenberg PB, Mielke MM, Appleby BS, Oh ES, Geda YE, Lyketsos CG. The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am J Geriatr Psychiatry. 2013;21(7):685\u201395.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"1386_CR68","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.3233\/JAD-170527","volume":"62","author":"MA Sugarman","year":"2018","unstructured":"Sugarman MA, Alosco ML, Tripodis Y, Steinberg EG, Stern RA. Neuropsychiatric symptoms and the diagnostic stability of mild cognitive impairment. J Alzheimers Dis. 2018;62(4):1841\u201355.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1386_CR69","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1017\/S1041610217001260","volume":"30","author":"P Desmarais","year":"2018","unstructured":"Desmarais P, Lanct\u00f4t KL, Masellis M, Black SE, Herrmann N. Social inappropriateness in neurodegenerative disorders. Int Psychogeriatr. 2018;30(2):197\u2013207.","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"1386_CR70","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1017\/S1041610217000874","volume":"30","author":"CE Fischer","year":"2018","unstructured":"Fischer CE, Ag\u00fcera-Ortiz L. Psychosis and dementia: risk factor, prodrome, or cause? Int Psychogeriatr. 2018;30(2):209\u201319.","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"1386_CR71","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41582-021-00597-3","volume":"18","author":"Z Ismail","year":"2022","unstructured":"Ismail Z, Creese B, Aarsland D, Kales HC, Lyketsos CG, Sweet RA, et al. Psychosis in Alzheimer disease\u2014mechanisms, genetics and therapeutic opportunities. Nat Rev Neurol. 2022;18(3):131\u201344.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1386_CR72","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3233\/JAD-190025","volume":"70","author":"S Dietlin","year":"2019","unstructured":"Dietlin S, Soto M, Kiyasova V, Pueyo M, de Mauleon A, Delrieu J, et al. Neuropsychiatric symptoms and risk of progression to Alzheimer\u2019s disease among mild cognitive impairment subjects. J Alzheimers Dis. 2019;70(1):25\u201334.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1386_CR73","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jamapsychiatry.2016.3162","volume":"74","author":"Z Ismail","year":"2017","unstructured":"Ismail Z, Elbayoumi H, Fischer CE, Hogan DB, Millikin CP, Schweizer T, et al. Prevalence of depression in patients with mild cognitive impairment: a systematic review and meta-analysis. JAMA Psychiat. 2017;74(1):58\u201367.","journal-title":"JAMA Psychiat"},{"issue":"6","key":"1386_CR74","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1212\/WNL.0000000000001238","volume":"84","author":"MC Masters","year":"2015","unstructured":"Masters MC, Morris JC, Roe CM. \u201cNoncognitive\u201d symptoms of early Alzheimer disease. Neurology. 2015;84(6):617\u201322.","journal-title":"Neurology"},{"issue":"2","key":"1386_CR75","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neulet.2009.03.007","volume":"455","author":"MA Slifer","year":"2009","unstructured":"Slifer MA, Martin ER, Gilbert JR, Haines JL, Pericak-Vance MA. Resolving the relationship between apolipoprotein E and depression. Neurosci Lett. 2009;455(2):116\u20139.","journal-title":"Neurosci Lett"},{"issue":"4","key":"1386_CR76","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.3233\/JAD-220586","volume":"90","author":"AS Dissanayake","year":"2022","unstructured":"Dissanayake AS, Tan YB, Bowie CR, Butters MA, Flint AJ, Gallagher D, et al. Sex modifies the associations of APOE \u025b4 with neuropsychiatric symptom burden in both at-risk and clinical cohorts of Alzheimer\u2019s disease. J Alzheimers Dis. 2022;90(4):1571\u201388.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1386_CR77","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1176\/jnp.12.2.233","volume":"12","author":"DI Kaufer","year":"2000","unstructured":"Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. JNP. 2000;12(2):233\u20139.","journal-title":"JNP"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01386-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-024-01386-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01386-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T06:02:51Z","timestamp":1706248971000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-024-01386-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,26]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1386"],"URL":"https:\/\/doi.org\/10.1186\/s13195-024-01386-y","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,26]]},"assertion":[{"value":"13 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent according to the Declaration of Helsinki. The study was approved by the Ethics Committee of Motol University Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ZI discloses consultancy to  Biogen,\u00a0Eisai, Novo Nordisk and Roche. All other authors declare no conflict of interest. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}